Exam 3 Flashcards
Viral Entry Inhibitors
Amantadine, Rimantadine, MOA: inhibits penetration of RNA virus into host cell (blocks influenza A virus M2 proton-selective ion channel)
Viral Entry Inhibitor Coverage
Influenza A ONLY
Viral Entry Inhibitor Pharmacology and PK
CNS entry, renal clearance, Convulsions w/ high doses (amantadine)
Neuraminidase Inhibitors
Zanamivir (Relenza) Nasal, Oseltamivir (Tamiflu) Oral, peramivir (Rapivab) IV, MOA: transition state that mimics the oxonium cation intermedicate of sialic acid
Neuraminidase Inhibitor Coverage
Influenza A and B
Zanamivir
Inhalation route only, Resistance against is caused by mutations in the NA active site, decreased binding of drug
Oseltamivir
prodrug, give w/ food, mechanism of resistance same as zanamirvir
Interferons
Used for the treatment of hepatitis virus
Interferon MOA
potent cytokines, activate the JAK/STAT pathway -> leads to protein synthesis that have antiviral effect (pegylated enhances T1/2)
Agents used to treat Herpes Virus
Nucleoside Analogs: Acyclovir, Valacyclovir, Famciclovir, Penciclovir, Cidofovir, Ganciclovir, Valganciclovir, Idoxuridine, (exception: Docosonol, Foscarnet) Trifluridine, Cytarabine
Acyclovir/Valacyclovir
lacks 3prime -OH, MOA: competitive inhibition of DNA polymerase, incorporate into DNA -> chain termination (valacyclovir has valine group, prodrug, Trojan horse like entry into body)
Acyclovir/Valacyclovir PK
Val. has increased F, renal elimination unchanged, Hallucinations w/ high doses
Famyclovir/Penciclovir
Fam is prodrug converted into penciclovir (used only topically), MOA: inhibits DNA polymerase, not a chain terminator though, long T1/2 vs acyclovir, ADE- urticaria, confusion
Cidofovir (Vistide)
synthetic, CMV and EBV coverage, too, NO PO, nephrotoxic
Ganciclovir/Valganciclovir
Valine prodrug ester present, MOA: like acyclovir, herpes & CMV, ADE: myelosuppression, nutropenia, thrombocytopenia, convulsions, coma